- Trials with a EudraCT protocol (163)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
163 result(s) found for: Beta Blocker.
Displaying page 1 of 9.
EudraCT Number: 2006-003991-37 | Sponsor Protocol Number: AGO/2006/009 | Start Date*: 2006-12-13 | |||||||||||
Sponsor Name:University Hospital Gent | |||||||||||||
Full Title: Trial of beta blocker therapy (atenolol) vs. angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome | |||||||||||||
Medical condition: Marfan syndrome | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000269-27 | Sponsor Protocol Number: DSCK101 | Start Date*: 2014-11-06 |
Sponsor Name:German Foundation for Chronically Ill | ||
Full Title: Efficacy and tolerance of Beta Blocker and Procoralan uptitration in chronic heart failure patients under telemedical control: „70 bpm on day 28“ | ||
Medical condition: Patients with chronic heart failure and resting heart rate of ≥ 75 bmp | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001998-25 | Sponsor Protocol Number: BLO K025 | Start Date*: 2006-09-29 | |||||||||||
Sponsor Name:Takeda Pharma GmbH | |||||||||||||
Full Title: Double-blind, randomised trial to investigate the antihypertensive and metabolic effects of candesartan in insulin-resistant obese patients with a hypertension not adequately controlled by previous... | |||||||||||||
Medical condition: Insulin-resistant obese patients with a hypertension not adequately controlled by previous beta-blocker or calcium channel blocker | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002699-42 | Sponsor Protocol Number: DANBLOCK | Start Date*: 2018-09-28 | |||||||||||
Sponsor Name:Bispebjerg Frederiksberg Hospital | |||||||||||||
Full Title: Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK) | |||||||||||||
Medical condition: Myocardial infarction. We wish to test whether long-term treatment with betablocker (bisoprolol, carvedilol, metoprolol or nebivolol) leads to better prognosis than no treatment in patients sufferi... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020424-21 | Sponsor Protocol Number: bbbipah.1 | Start Date*: 2011-01-10 | |||||||||||
Sponsor Name:VU medical center | |||||||||||||
Full Title: Betablocker Therapy in Pulmonary Arterial Hypertension | |||||||||||||
Medical condition: Idiopathic pulmonal arterial hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000486-37 | Sponsor Protocol Number: CHF201701 | Start Date*: 2019-03-27 |
Sponsor Name:Heart Initiative | ||
Full Title: STRONG-HF: Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP testing, of Heart Failure therapies | ||
Medical condition: Acute Heart Failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) HR (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-004329-90 | Sponsor Protocol Number: OGTT Version 3. 18.05.07 | Start Date*: 2005-02-08 |
Sponsor Name:CAMBRIDGE UNIVERSITY HOSPITALS FOUNDATION NHS TRUST | ||
Full Title: EARLY METABOLIC CHANGES WITH THIAZIDE OR BETA BLOCKER THERAPY FOR ESSENTIAL HYPERTENSION (MAIN STUDY). | ||
Medical condition: ESSENTIAL HYPERTENSION | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-003377-15 | Sponsor Protocol Number: ERASMUS2007,Sofia2 | Start Date*: 2007-08-30 |
Sponsor Name:Erasmus Hospital | ||
Full Title: Chemoreflex sensitivity, exercise and beta agonists | ||
Medical condition: Healthy participants | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-000957-47 | Sponsor Protocol Number: 12052004 | Start Date*: 2007-11-22 |
Sponsor Name:Charité | ||
Full Title: Comparison of Bisoprolol and Carvedilol in elderly patients with heart failure. A randomised doubleblind multicenter trial | ||
Medical condition: Patients, 65 years or older, suffering from chronic heart failure and who are so far not treated with betablockers or treated with a low dose betablocker (<1/4 standard dose) | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SI (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-000207-13 | Sponsor Protocol Number: 2012RC22 | Start Date*: 2015-09-17 | |||||||||||
Sponsor Name:Tayside Clinical Trials Unit, University of Dundee | |||||||||||||
Full Title: Proof of concept study to assess the differential effects of chronic beta-blockade (celiprolol versus bisoprolol) on cardiopulmonary outcomes at rest and during exercise in chronic obstructive pulm... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002485-40 | Sponsor Protocol Number: REBOOT-CNIC | Start Date*: 2018-03-22 |
Sponsor Name:CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (CNIC) | ||
Full Title: treatment with beta-blockers after myocardial infarction without reduced ejection fraction | ||
Medical condition: STEMI or NSTEMI patients being discharged from the index hospitalization with a LVEF>40% without previous heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002512-89 | Sponsor Protocol Number: ANDA1 | Start Date*: 2012-01-26 | |||||||||||
Sponsor Name:Tayside Clinical Trials Unit, University of Dundee | |||||||||||||
Full Title: Evaluation of any steroid sparing effect of beta blocker therapy on airway hyper-responsiveness in stable, mild to moderate, asthmatics. | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001509-40 | Sponsor Protocol Number: BETAVASC-IV-08-1 | Start Date*: 2008-10-18 |
Sponsor Name:Hungarian Kidney Foundation | ||
Full Title: Effects of beta blockers on central arterial pressure and vascular stiffness | ||
Medical condition: Patients with hypertension and/or ischemic heart disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004169-13 | Sponsor Protocol Number: 1 | Start Date*: 2005-05-19 |
Sponsor Name:south manchester university hospital nhs trust | ||
Full Title: A Pilot study to assess the effects of beta-blockade on exercise capacity and BNP levels in patients with predominantly diastolic heart failure | ||
Medical condition: Diastolic heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2020-000934-16 | Sponsor Protocol Number: Nl.060.44183 | Start Date*: 2020-06-18 |
Sponsor Name:TNO | ||
Full Title: Reconsolidation: a new intervention towards combat-related PTSD. | ||
Medical condition: Post-traumatic stress disorder. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-005082-47 | Sponsor Protocol Number: HUS/1209/2017 | Start Date*: 2018-09-24 |
Sponsor Name:Sydän- ja keuhkokeskus, HUS | ||
Full Title: Repolarization study in LQTS patients | ||
Medical condition: Long QT syndrome (LQTS) is a hereditary arrhythmia disease. It causes disturbances to the ion flow through cell membranes of cardiomyocytes. These disturbances can sometimes seen in an electrocardi... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003563-26 | Sponsor Protocol Number: NL74799.018.20 | Start Date*: 2020-10-15 |
Sponsor Name:TNO | ||
Full Title: Reconsolidation: a new intervention for traumatized healthcare workers. | ||
Medical condition: Post-traumatic stress disorder. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-018215-53 | Sponsor Protocol Number: AFRODITE | Start Date*: 2010-02-10 | ||||||||||||||||
Sponsor Name:sanofi-aventis Netherlands | ||||||||||||||||||
Full Title: The effect of the addition of dronedarone to, versus increase of, existing conventional rate control medication on ventricular rate during paroxysmal or persistent atrial fibrillation (AFRODITE study) | ||||||||||||||||||
Medical condition: atrial fibrillation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-004014-16 | Sponsor Protocol Number: CSPP100A2313 | Start Date*: 2005-04-07 |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: A twelve-week, randomized, double-blind, multi-center, placebo controlled, parallel group study to evaluate the safety and efficacy of aliskiren 150 mg when added to standard therapy in patients wi... | ||
Medical condition: Hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) IT (Completed) DE (Completed) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-004608-37 | Sponsor Protocol Number: FER-CARS-02 | Start Date*: 2007-07-27 | |||||||||||
Sponsor Name:Vifor Pharma, Vifor (International) Ltd. | |||||||||||||
Full Title: A randomised double-blind controlled phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose (Ferinject®) with placebo in patients with chronic heart failure and iro... | |||||||||||||
Medical condition: iron deficiency in patients with chronic heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) IT (Completed) CZ (Completed) GR (Completed) SE (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.